Jens Pohlmann

In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939—an oral, direct Factor Xa inhibitor

Elisabeth Perzborn, Andreas Wilmen, Jens Pohlmann et al. · Journal of Thrombosis and Haemostasis · 2005 · 583 citations · Full text

Molecular Pharmacology, Thrombosis, Vivo Studies +9

Discovery of the Novel Antithrombotic Agent 5-Chloro-<i>N</i>-({(5<i>S</i>)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939):  An Oral, Direct Factor Xa Inhibitor

Susanne Roehrig, Alexander Straub, Jens Pohlmann et al. · Journal of Medicinal Chemistry · 2005 · 429 citations · Full text

Pharmacotherapy, Chemical Biology, Pharmaceutical Chemistry +17

Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells

Don Benjamin, Dimitri Robay, Sravanth K. Hindupur et al. · Cell Reports · 2018 · 353 citations · Full text

The Novel Microtubule-Destabilizing Drug BAL27862 Binds to the Colchicine Site of Tubulin with Distinct Effects on Microtubule Organization

A.E. Prota, Franck Danel, Felix Bachmann et al. · Journal of Molecular Biology · 2014 · 299 citations

Microtubule Organization, Protein Function, Molecular Biology +7

Identification and Characterization of the First Class of Potent Bacterial Acetyl-CoA Carboxylase Inhibitors with Antibacterial Activity

Christoph Freiberg, Nina Brunner, Guido Schiffer et al. · Journal of Biological Chemistry · 2004 · 213 citations · Full text